

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.41663715 |
| 2 | viral transcription (GO:0019083) | 6.55517827 |
| 3 | maintenance of protein location in nucleus (GO:0051457) | 6.41866710 |
| 4 | * SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.41692565 |
| 5 | * cotranslational protein targeting to membrane (GO:0006613) | 6.31256425 |
| 6 | * protein targeting to ER (GO:0045047) | 6.27428521 |
| 7 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 6.24120805 |
| 8 | somite rostral/caudal axis specification (GO:0032525) | 6.23638001 |
| 9 | protein localization to kinetochore (GO:0034501) | 6.22242490 |
| 10 | translational termination (GO:0006415) | 6.21809786 |
| 11 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 6.17662746 |
| 12 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 6.10662982 |
| 13 | ribosomal small subunit assembly (GO:0000028) | 6.04757014 |
| 14 | * protein localization to endoplasmic reticulum (GO:0070972) | 5.97919332 |
| 15 | * establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.97511133 |
| 16 | ribosomal small subunit biogenesis (GO:0042274) | 5.88204681 |
| 17 | regulation of response to osmotic stress (GO:0047484) | 5.79626916 |
| 18 | regulation of telomere maintenance via telomerase (GO:0032210) | 5.78846565 |
| 19 | negative regulation of telomerase activity (GO:0051974) | 5.66281855 |
| 20 | negative regulation of epidermis development (GO:0045683) | 5.62844425 |
| 21 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 5.59518230 |
| 22 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.56815379 |
| 23 | regulation of MHC class I biosynthetic process (GO:0045343) | 5.48511614 |
| 24 | translational elongation (GO:0006414) | 5.45358305 |
| 25 | rRNA transcription (GO:0009303) | 5.30570039 |
| 26 | histone H4-K12 acetylation (GO:0043983) | 5.27861945 |
| 27 | viral life cycle (GO:0019058) | 5.18687253 |
| 28 | muscle organ morphogenesis (GO:0048644) | 5.14390340 |
| 29 | histone H4-K5 acetylation (GO:0043981) | 5.07781156 |
| 30 | histone H4-K8 acetylation (GO:0043982) | 5.07781156 |
| 31 | Golgi transport vesicle coating (GO:0048200) | 5.05979377 |
| 32 | COPI coating of Golgi vesicle (GO:0048205) | 5.05979377 |
| 33 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.00541003 |
| 34 | mitotic sister chromatid segregation (GO:0000070) | 4.89687764 |
| 35 | cytidine deamination (GO:0009972) | 4.87933714 |
| 36 | cytidine metabolic process (GO:0046087) | 4.87933714 |
| 37 | cytidine catabolic process (GO:0006216) | 4.87933714 |
| 38 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.85049596 |
| 39 | notochord development (GO:0030903) | 4.79485498 |
| 40 | rRNA methylation (GO:0031167) | 4.73980583 |
| 41 | cellular protein complex disassembly (GO:0043624) | 4.72823832 |
| 42 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.69400731 |
| 43 | translational initiation (GO:0006413) | 4.68387636 |
| 44 | nucleoside transmembrane transport (GO:1901642) | 4.60136872 |
| 45 | regulation of translation in response to stress (GO:0043555) | 4.58032754 |
| 46 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.55640231 |
| 47 | ATP synthesis coupled proton transport (GO:0015986) | 4.55640231 |
| 48 | quinone metabolic process (GO:1901661) | 4.54715168 |
| 49 | protein localization to chromosome, centromeric region (GO:0071459) | 4.54417161 |
| 50 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.54224253 |
| 51 | regulation of cilium movement (GO:0003352) | 4.51088151 |
| 52 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.49688362 |
| 53 | DNA replication-dependent nucleosome organization (GO:0034723) | 4.47078532 |
| 54 | DNA replication-dependent nucleosome assembly (GO:0006335) | 4.47078532 |
| 55 | rRNA modification (GO:0000154) | 4.46150811 |
| 56 | DNA replication checkpoint (GO:0000076) | 4.45713211 |
| 57 | coenzyme catabolic process (GO:0009109) | 4.45234097 |
| 58 | hormone catabolic process (GO:0042447) | 4.44552282 |
| 59 | negative regulation of telomere maintenance (GO:0032205) | 4.44191495 |
| 60 | response to dietary excess (GO:0002021) | 4.41701161 |
| 61 | cullin deneddylation (GO:0010388) | 4.41136501 |
| 62 | * protein targeting to membrane (GO:0006612) | 4.37263036 |
| 63 | maturation of SSU-rRNA (GO:0030490) | 4.35819699 |
| 64 | phenol-containing compound catabolic process (GO:0019336) | 4.34957626 |
| 65 | heterochromatin organization (GO:0070828) | 4.33145844 |
| 66 | ribosomal large subunit biogenesis (GO:0042273) | 4.30328862 |
| 67 | primitive streak formation (GO:0090009) | 4.29872820 |
| 68 | * translation (GO:0006412) | 4.29147311 |
| 69 | GDP-mannose metabolic process (GO:0019673) | 4.22719659 |
| 70 | protein maturation by protein folding (GO:0022417) | 4.22438488 |
| 71 | maintenance of protein localization in organelle (GO:0072595) | 4.16633561 |
| 72 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.14572054 |
| 73 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 4.07627278 |
| 74 | sister chromatid segregation (GO:0000819) | 4.03228205 |
| 75 | interferon-gamma production (GO:0032609) | 4.00301464 |
| 76 | protein complex disassembly (GO:0043241) | 3.98541152 |
| 77 | chromatin assembly (GO:0031497) | 3.95411932 |
| 78 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.93902201 |
| 79 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.93351188 |
| 80 | protein deneddylation (GO:0000338) | 3.91972544 |
| 81 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.91180618 |
| 82 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.88650578 |
| 83 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.86134047 |
| 84 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.83334876 |
| 85 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.83334876 |
| 86 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.82761106 |
| 87 | negative regulation of ligase activity (GO:0051352) | 3.82761106 |
| 88 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.79216026 |
| 89 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.79216026 |
| 90 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.79216026 |
| 91 | macromolecular complex disassembly (GO:0032984) | 3.77456407 |
| 92 | nuclear pore complex assembly (GO:0051292) | 3.76423344 |
| 93 | intestinal epithelial cell development (GO:0060576) | 3.76081736 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.70720248 |
| 95 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.70285676 |
| 96 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.70285676 |
| 97 | formation of translation preinitiation complex (GO:0001731) | 3.70214188 |
| 98 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.66137188 |
| 99 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.62192431 |
| 100 | histone H4-K16 acetylation (GO:0043984) | 3.61087669 |
| 101 | cellular modified amino acid catabolic process (GO:0042219) | 3.59881249 |
| 102 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.57948033 |
| 103 | regulation of telomerase activity (GO:0051972) | 3.57018621 |
| 104 | proteasome assembly (GO:0043248) | 3.53308402 |
| 105 | ribosome biogenesis (GO:0042254) | 3.51679366 |
| 106 | positive regulation of protein deacetylation (GO:0090312) | 3.48316428 |
| 107 | cardiovascular system development (GO:0072358) | 3.48282747 |
| 108 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.47605484 |
| 109 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.45597380 |
| 110 | maternal placenta development (GO:0001893) | 3.45469225 |
| 111 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.45169816 |
| 112 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.45012195 |
| 113 | nucleoside transport (GO:0015858) | 3.44255916 |
| 114 | respiratory electron transport chain (GO:0022904) | 3.41142628 |
| 115 | nuclear pore organization (GO:0006999) | 3.39559120 |
| 116 | chaperone-mediated protein transport (GO:0072321) | 3.36250477 |
| 117 | electron transport chain (GO:0022900) | 3.36234669 |
| 118 | mitochondrion distribution (GO:0048311) | 3.35912035 |
| 119 | protein retention in ER lumen (GO:0006621) | 3.35135035 |
| 120 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.34808603 |
| 121 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.34527673 |
| 122 | regulation of telomere maintenance (GO:0032204) | 3.33258519 |
| 123 | bone trabecula formation (GO:0060346) | 3.30774376 |
| 124 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.30559732 |
| 125 | viral protein processing (GO:0019082) | 3.28751870 |
| 126 | pseudouridine synthesis (GO:0001522) | 3.28193284 |
| 127 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.27579730 |
| 128 | transcription from mitochondrial promoter (GO:0006390) | 3.26702383 |
| 129 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.26431607 |
| 130 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.25996107 |
| 131 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.24602249 |
| 132 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.24602249 |
| 133 | DNA damage response, detection of DNA damage (GO:0042769) | 3.24565553 |
| 134 | trophectodermal cell differentiation (GO:0001829) | 3.23393272 |
| 135 | retinoic acid receptor signaling pathway (GO:0048384) | 3.19064245 |
| 136 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.18104790 |
| 137 | mRNA catabolic process (GO:0006402) | 3.16455568 |
| 138 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.15257659 |
| 139 | regulation of gene silencing by miRNA (GO:0060964) | 3.15257659 |
| 140 | regulation of gene silencing by RNA (GO:0060966) | 3.15257659 |
| 141 | positive regulation of ligase activity (GO:0051351) | 3.14761188 |
| 142 | epoxygenase P450 pathway (GO:0019373) | 3.13111475 |
| 143 | * establishment of protein localization to membrane (GO:0090150) | 3.13078800 |
| 144 | positive regulation of cell cycle arrest (GO:0071158) | 3.12256541 |
| 145 | RNA stabilization (GO:0043489) | 3.11523564 |
| 146 | mRNA stabilization (GO:0048255) | 3.11523564 |
| 147 | vitamin A metabolic process (GO:0006776) | 3.09587080 |
| 148 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.08738845 |
| 149 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.07340994 |
| 150 | protein targeting to mitochondrion (GO:0006626) | 3.07126047 |
| 151 | DNA duplex unwinding (GO:0032508) | 3.06848629 |
| 152 | arachidonic acid secretion (GO:0050482) | 3.05672877 |
| 153 | icosanoid secretion (GO:0032309) | 3.05672877 |
| 154 | virion assembly (GO:0019068) | 3.04565130 |
| 155 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.04501086 |
| 156 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.03584841 |
| 157 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.02461317 |
| 158 | DNA geometric change (GO:0032392) | 3.02331516 |
| 159 | positive regulation of histone deacetylation (GO:0031065) | 3.01155081 |
| 160 | cellular component biogenesis (GO:0044085) | 2.98967972 |
| 161 | GTP biosynthetic process (GO:0006183) | 2.98357517 |
| 162 | microtubule severing (GO:0051013) | 2.98135339 |
| 163 | regulation of mitochondrial translation (GO:0070129) | 2.96574598 |
| 164 | pre-miRNA processing (GO:0031054) | 2.95333120 |
| 165 | regulation of microtubule-based movement (GO:0060632) | 2.95021627 |
| 166 | cofactor transport (GO:0051181) | 2.94797187 |
| 167 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.94651111 |
| 168 | apoptotic DNA fragmentation (GO:0006309) | 2.93688253 |
| 169 | * protein targeting (GO:0006605) | 2.91176414 |
| 170 | peptidyl-histidine modification (GO:0018202) | 2.89945952 |
| 171 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.88252892 |
| 172 | establishment of protein localization to mitochondrion (GO:0072655) | 2.86479608 |
| 173 | regulation of cellular amine metabolic process (GO:0033238) | 2.85189502 |
| 174 | amyloid precursor protein catabolic process (GO:0042987) | 2.84694702 |
| 175 | RNA catabolic process (GO:0006401) | 2.82688518 |
| 176 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.81517218 |
| 177 | termination of RNA polymerase III transcription (GO:0006386) | 2.81517218 |
| 178 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.81327166 |
| 179 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.79309964 |
| 180 | mannosylation (GO:0097502) | 2.79138413 |
| 181 | UTP biosynthetic process (GO:0006228) | 2.79134161 |
| 182 | base-excision repair, AP site formation (GO:0006285) | 2.74971827 |
| 183 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.71002055 |
| 184 | regulation of ligase activity (GO:0051340) | 2.70663810 |
| 185 | CTP metabolic process (GO:0046036) | 2.70153901 |
| 186 | CTP biosynthetic process (GO:0006241) | 2.70153901 |
| 187 | regulation of cell cycle arrest (GO:0071156) | 2.69760334 |
| 188 | negative regulation of protein ubiquitination (GO:0031397) | 2.67970591 |
| 189 | protein localization to mitochondrion (GO:0070585) | 2.66191121 |
| 190 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.61924352 |
| 191 | protein complex biogenesis (GO:0070271) | 2.61623093 |
| 192 | cell redox homeostasis (GO:0045454) | 2.61553739 |
| 193 | daunorubicin metabolic process (GO:0044597) | 11.4539744 |
| 194 | polyketide metabolic process (GO:0030638) | 11.4539744 |
| 195 | doxorubicin metabolic process (GO:0044598) | 11.4539744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 6.03825622 |
| 2 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 6.03825622 |
| 3 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 6.03825622 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.71752677 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.68437934 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.63329956 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.68141993 |
| 8 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.07244000 |
| 9 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.96663412 |
| 10 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.95160128 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.70600110 |
| 12 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.66163530 |
| 13 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.50008463 |
| 14 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.34130389 |
| 15 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.31513456 |
| 16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.28482746 |
| 17 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.22059273 |
| 18 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.21907705 |
| 19 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.14418096 |
| 20 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.07224317 |
| 21 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.05972082 |
| 22 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.05542736 |
| 23 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.04305746 |
| 24 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 2.01881162 |
| 25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.01102055 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.99769746 |
| 27 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.94924975 |
| 28 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.90631762 |
| 29 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.90072125 |
| 30 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.88181639 |
| 31 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.88110172 |
| 32 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.84940715 |
| 33 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.84368027 |
| 34 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.84267083 |
| 35 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.83165808 |
| 36 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.81591078 |
| 37 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.78752405 |
| 38 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78659822 |
| 39 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.78651542 |
| 40 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.77783792 |
| 41 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.77235142 |
| 42 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.77149605 |
| 43 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.75541810 |
| 44 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.75479775 |
| 45 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.74483000 |
| 46 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.74349278 |
| 47 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.73048575 |
| 48 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.69872169 |
| 49 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.68300372 |
| 50 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.68248143 |
| 51 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.67019063 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66956543 |
| 53 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.62772719 |
| 54 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.60395044 |
| 55 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.59580396 |
| 56 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.55404540 |
| 57 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.53960738 |
| 58 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.46203794 |
| 59 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.45192959 |
| 60 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.44837330 |
| 61 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.43457507 |
| 62 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.41897653 |
| 63 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41638170 |
| 64 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39298405 |
| 65 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.38122995 |
| 66 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.37812539 |
| 67 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36769712 |
| 68 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.35456087 |
| 69 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.35228155 |
| 70 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.34058650 |
| 71 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.32733329 |
| 72 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.31354412 |
| 73 | MYC_22102868_ChIP-Seq_BL_Human | 1.30549030 |
| 74 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.28902888 |
| 75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.28311575 |
| 76 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.28229583 |
| 77 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.27365340 |
| 78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26252527 |
| 79 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.25885813 |
| 80 | * SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.25400549 |
| 81 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24779361 |
| 82 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.24673963 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24110688 |
| 84 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.21335137 |
| 85 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.19896620 |
| 86 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.19361101 |
| 87 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.19131189 |
| 88 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.18939384 |
| 89 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.17707113 |
| 90 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14409883 |
| 91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.14042263 |
| 92 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.13228195 |
| 93 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.12683045 |
| 94 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.12211666 |
| 95 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.10097517 |
| 96 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.07952277 |
| 97 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06929721 |
| 98 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.06882398 |
| 99 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.06698917 |
| 100 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.06559060 |
| 101 | * NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.05656186 |
| 102 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04724375 |
| 103 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.04657658 |
| 104 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.04443870 |
| 105 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03801365 |
| 106 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02458408 |
| 107 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.00670714 |
| 108 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00177991 |
| 109 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.99573062 |
| 110 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.99041918 |
| 111 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.98109663 |
| 112 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97759433 |
| 113 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.97646872 |
| 114 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.96985510 |
| 115 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.96176747 |
| 116 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.93190280 |
| 117 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.93031341 |
| 118 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.92382328 |
| 119 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91349346 |
| 120 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.91172052 |
| 121 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.90975696 |
| 122 | * XRN2_22483619_ChIP-Seq_HELA_Human | 0.90073989 |
| 123 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.89944293 |
| 124 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.89457299 |
| 125 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.88663277 |
| 126 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.87552765 |
| 127 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.87249792 |
| 128 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86333938 |
| 129 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.85964056 |
| 130 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.85269029 |
| 131 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.85126698 |
| 132 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.84567779 |
| 133 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.83535418 |
| 134 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.82979814 |
| 135 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.82141245 |
| 136 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.80441624 |
| 137 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.80213529 |
| 138 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.80012269 |
| 139 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.79986473 |
| 140 | * KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.78290974 |
| 141 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.76879696 |
| 142 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.76391448 |
| 143 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75805041 |
| 144 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 0.75141519 |
| 145 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.74960333 |
| 146 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.74860524 |
| 147 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.73275585 |
| 148 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.71731497 |
| 149 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.71530296 |
| 150 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.71498070 |
| 151 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.71325802 |
| 152 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.70344088 |
| 153 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.70205952 |
| 154 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.70058229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.88299371 |
| 2 | MP0004264_abnormal_extraembryonic_tissu | 4.67244743 |
| 3 | MP0003011_delayed_dark_adaptation | 4.28826580 |
| 4 | MP0002254_reproductive_system_inflammat | 4.11526485 |
| 5 | MP0006292_abnormal_olfactory_placode | 4.08112170 |
| 6 | MP0003890_abnormal_embryonic-extraembry | 3.62196250 |
| 7 | MP0009379_abnormal_foot_pigmentation | 3.30833573 |
| 8 | MP0005075_abnormal_melanosome_morpholog | 3.24510329 |
| 9 | MP0008057_abnormal_DNA_replication | 3.17840332 |
| 10 | MP0004957_abnormal_blastocyst_morpholog | 3.15791925 |
| 11 | MP0003122_maternal_imprinting | 3.07841144 |
| 12 | MP0005394_taste/olfaction_phenotype | 2.97769622 |
| 13 | MP0005499_abnormal_olfactory_system | 2.97769622 |
| 14 | MP0005408_hypopigmentation | 2.93443461 |
| 15 | MP0000678_abnormal_parathyroid_gland | 2.82134441 |
| 16 | MP0004858_abnormal_nervous_system | 2.79463586 |
| 17 | MP0000372_irregular_coat_pigmentation | 2.69459076 |
| 18 | MP0005257_abnormal_intraocular_pressure | 2.59089010 |
| 19 | MP0002332_abnormal_exercise_endurance | 2.56633465 |
| 20 | MP0005058_abnormal_lysosome_morphology | 2.42801649 |
| 21 | MP0002653_abnormal_ependyma_morphology | 2.29841015 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 2.28214348 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 2.26287817 |
| 24 | MP0003121_genomic_imprinting | 2.25849345 |
| 25 | MP0006035_abnormal_mitochondrial_morpho | 2.22631859 |
| 26 | MP0009840_abnormal_foam_cell | 2.10032524 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.07175254 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.89751332 |
| 29 | MP0005380_embryogenesis_phenotype | 1.88527094 |
| 30 | MP0001672_abnormal_embryogenesis/_devel | 1.88527094 |
| 31 | MP0005503_abnormal_tendon_morphology | 1.82693082 |
| 32 | MP0001542_abnormal_bone_strength | 1.79675611 |
| 33 | MP0002088_abnormal_embryonic_growth/wei | 1.75676174 |
| 34 | MP0003984_embryonic_growth_retardation | 1.74480422 |
| 35 | MP0003123_paternal_imprinting | 1.67822851 |
| 36 | MP0006054_spinal_hemorrhage | 1.66386985 |
| 37 | MP0010030_abnormal_orbit_morphology | 1.61178387 |
| 38 | MP0003279_aneurysm | 1.58059819 |
| 39 | MP0003077_abnormal_cell_cycle | 1.57013438 |
| 40 | MP0003938_abnormal_ear_development | 1.55821616 |
| 41 | MP0002127_abnormal_cardiovascular_syste | 1.54761366 |
| 42 | MP0000350_abnormal_cell_proliferation | 1.53753817 |
| 43 | MP0001293_anophthalmia | 1.53230455 |
| 44 | MP0008961_abnormal_basal_metabolism | 1.52786764 |
| 45 | MP0000049_abnormal_middle_ear | 1.51855111 |
| 46 | MP0001853_heart_inflammation | 1.48072704 |
| 47 | MP0001849_ear_inflammation | 1.47995464 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.47913088 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.46186946 |
| 50 | MP0003283_abnormal_digestive_organ | 1.45865345 |
| 51 | MP0005360_urolithiasis | 1.42252310 |
| 52 | MP0004043_abnormal_pH_regulation | 1.40963052 |
| 53 | MP0002938_white_spotting | 1.39461720 |
| 54 | MP0005266_abnormal_metabolism | 1.37702594 |
| 55 | MP0002932_abnormal_joint_morphology | 1.37270355 |
| 56 | MP0000762_abnormal_tongue_morphology | 1.33386871 |
| 57 | MP0002086_abnormal_extraembryonic_tissu | 1.32677867 |
| 58 | MP0006082_CNS_inflammation | 1.32045654 |
| 59 | MP0004133_heterotaxia | 1.31609594 |
| 60 | MP0002085_abnormal_embryonic_tissue | 1.31515311 |
| 61 | MP0002092_abnormal_eye_morphology | 1.31405049 |
| 62 | MP0003941_abnormal_skin_development | 1.28802351 |
| 63 | MP0005171_absent_coat_pigmentation | 1.26648397 |
| 64 | MP0003119_abnormal_digestive_system | 1.26177556 |
| 65 | MP0003111_abnormal_nucleus_morphology | 1.25928117 |
| 66 | MP0000858_altered_metastatic_potential | 1.25473960 |
| 67 | MP0005275_abnormal_skin_tensile | 1.25403961 |
| 68 | MP0008789_abnormal_olfactory_epithelium | 1.24862309 |
| 69 | MP0009785_altered_susceptibility_to | 1.22616227 |
| 70 | MP0001873_stomach_inflammation | 1.20244236 |
| 71 | MP0003693_abnormal_embryo_hatching | 1.18588683 |
| 72 | MP0002084_abnormal_developmental_patter | 1.17031366 |
| 73 | MP0001348_abnormal_lacrimal_gland | 1.15945024 |
| 74 | MP0002396_abnormal_hematopoietic_system | 1.15261466 |
| 75 | MP0001764_abnormal_homeostasis | 1.15158560 |
| 76 | MP0005197_abnormal_uvea_morphology | 1.15050584 |
| 77 | MP0003950_abnormal_plasma_membrane | 1.14889170 |
| 78 | MP0002163_abnormal_gland_morphology | 1.13607060 |
| 79 | MP0000613_abnormal_salivary_gland | 1.13339143 |
| 80 | MP0008932_abnormal_embryonic_tissue | 1.12395969 |
| 81 | MP0004197_abnormal_fetal_growth/weight/ | 1.11899590 |
| 82 | MP0010094_abnormal_chromosome_stability | 1.11510786 |
| 83 | MP0002060_abnormal_skin_morphology | 1.11361109 |
| 84 | MP0003436_decreased_susceptibility_to | 1.11110672 |
| 85 | MP0002233_abnormal_nose_morphology | 1.10913415 |
| 86 | MP0002148_abnormal_hypersensitivity_rea | 1.07215380 |
| 87 | MP0002970_abnormal_white_adipose | 1.05414434 |
| 88 | MP0000490_abnormal_crypts_of | 1.05094338 |
| 89 | MP0000685_abnormal_immune_system | 1.04826774 |
| 90 | MP0008260_abnormal_autophagy | 1.04785655 |
| 91 | MP0005508_abnormal_skeleton_morphology | 1.04382964 |
| 92 | MP0002114_abnormal_axial_skeleton | 1.04203028 |
| 93 | MP0001881_abnormal_mammary_gland | 1.04177522 |
| 94 | MP0001243_abnormal_dermal_layer | 1.03870465 |
| 95 | MP0002877_abnormal_melanocyte_morpholog | 1.03500879 |
| 96 | MP0001730_embryonic_growth_arrest | 1.03493544 |
| 97 | MP0000432_abnormal_head_morphology | 1.01609749 |
| 98 | MP0000428_abnormal_craniofacial_morphol | 0.99956480 |
| 99 | MP0000313_abnormal_cell_death | 0.99891574 |
| 100 | MP0003755_abnormal_palate_morphology | 0.99796105 |
| 101 | MP0003935_abnormal_craniofacial_develop | 0.98653097 |
| 102 | MP0008007_abnormal_cellular_replicative | 0.97753133 |
| 103 | MP0008058_abnormal_DNA_repair | 0.96779418 |
| 104 | MP0002295_abnormal_pulmonary_circulatio | 0.96299008 |
| 105 | MP0000343_altered_response_to | 0.96142078 |
| 106 | MP0001845_abnormal_inflammatory_respons | 0.94077476 |
| 107 | MP0001697_abnormal_embryo_size | 0.93592797 |
| 108 | MP0005084_abnormal_gallbladder_morpholo | 0.93544512 |
| 109 | MP0008469_abnormal_protein_level | 0.93246932 |
| 110 | MP0002080_prenatal_lethality | 0.91637900 |
| 111 | MP0005379_endocrine/exocrine_gland_phen | 0.91506409 |
| 112 | MP0002751_abnormal_autonomic_nervous | 0.90733266 |
| 113 | MP0000750_abnormal_muscle_regeneration | 0.88246984 |
| 114 | MP0003136_yellow_coat_color | 0.87890842 |
| 115 | MP0002132_abnormal_respiratory_system | 0.87167191 |
| 116 | MP0005023_abnormal_wound_healing | 0.86611235 |
| 117 | MP0009384_cardiac_valve_regurgitation | 0.86574278 |
| 118 | MP0005025_abnormal_response_to | 0.85435854 |
| 119 | MP0005671_abnormal_response_to | 0.85223270 |
| 120 | MP0005501_abnormal_skin_physiology | 0.85093350 |
| 121 | MP0010155_abnormal_intestine_physiology | 0.84243261 |
| 122 | MP0005193_abnormal_anterior_eye | 0.82777887 |
| 123 | MP0005391_vision/eye_phenotype | 0.82515402 |
| 124 | MP0005319_abnormal_enzyme/_coenzyme | 0.82181652 |
| 125 | MP0009053_abnormal_anal_canal | 0.82059536 |
| 126 | MP0004019_abnormal_vitamin_homeostasis | 0.81745866 |
| 127 | MP0000358_abnormal_cell_content/ | 0.80067036 |
| 128 | MP0005390_skeleton_phenotype | 0.80045455 |
| 129 | MP0001270_distended_abdomen | 0.78058994 |
| 130 | MP0001666_abnormal_nutrient_absorption | 0.78031197 |
| 131 | MP0002925_abnormal_cardiovascular_devel | 0.77906295 |
| 132 | MP0003806_abnormal_nucleotide_metabolis | 0.76790713 |
| 133 | MP0005248_abnormal_Harderian_gland | 0.76349917 |
| 134 | MP0002116_abnormal_craniofacial_bone | 0.76265111 |
| 135 | MP0009703_decreased_birth_body | 0.76192377 |
| 136 | MP0005365_abnormal_bile_salt | 0.76141798 |
| 137 | MP0008770_decreased_survivor_rate | 0.75944532 |
| 138 | MP0009643_abnormal_urine_homeostasis | 0.75094320 |
| 139 | MP0001286_abnormal_eye_development | 0.74445210 |
| 140 | MP0001533_abnormal_skeleton_physiology | 0.73991832 |
| 141 | MP0001661_extended_life_span | 0.72673131 |
| 142 | MP0008995_early_reproductive_senescence | 0.72329675 |
| 143 | MP0003787_abnormal_imprinting | 0.72261315 |
| 144 | MP0004782_abnormal_surfactant_physiolog | 0.71725555 |
| 145 | MP0000749_muscle_degeneration | 0.71681855 |
| 146 | MP0002098_abnormal_vibrissa_morphology | 0.71190659 |
| 147 | MP0002933_joint_inflammation | 0.71129561 |
| 148 | MP0003795_abnormal_bone_structure | 0.70924397 |
| 149 | MP0005165_increased_susceptibility_to | 0.70906558 |
| 150 | MP0003566_abnormal_cell_adhesion | 0.70011887 |
| 151 | MP0005083_abnormal_biliary_tract | 0.69894548 |
| 152 | MP0002269_muscular_atrophy | 0.69761457 |
| 153 | MP0004381_abnormal_hair_follicle | 0.69666992 |
| 154 | MP0001727_abnormal_embryo_implantation | 0.69419458 |
| 155 | MP0003315_abnormal_perineum_morphology | 0.69384684 |
| 156 | MP0002139_abnormal_hepatobiliary_system | 0.68723868 |
| 157 | MP0002095_abnormal_skin_pigmentation | 0.68119617 |
| 158 | MP0000538_abnormal_urinary_bladder | 0.67583666 |
| 159 | MP0003763_abnormal_thymus_physiology | 0.67132712 |
| 160 | MP0005164_abnormal_response_to | 0.66031863 |
| 161 | MP0004272_abnormal_basement_membrane | 0.65915023 |
| 162 | MP0003137_abnormal_impulse_conducting | 0.65907402 |
| 163 | MP0002419_abnormal_innate_immunity | 0.65252870 |
| 164 | MP0003186_abnormal_redox_activity | 0.64817603 |
| 165 | MP0003937_abnormal_limbs/digits/tail_de | 0.64758851 |
| 166 | MP0006036_abnormal_mitochondrial_physio | 0.63627615 |
| 167 | MP0003786_premature_aging | 0.62228925 |
| 168 | MP0000163_abnormal_cartilage_morphology | 0.61699190 |
| 169 | MP0005384_cellular_phenotype | 0.60239477 |
| 170 | MP0002249_abnormal_larynx_morphology | 0.58923995 |
| 171 | MP0002111_abnormal_tail_morphology | 0.58841580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 7.41902792 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 5.72893411 |
| 3 | Hepatoblastoma (HP:0002884) | 5.72624319 |
| 4 | Multiple enchondromatosis (HP:0005701) | 5.33408102 |
| 5 | Reticulocytopenia (HP:0001896) | 4.65528278 |
| 6 | Rib fusion (HP:0000902) | 4.61535274 |
| 7 | Abnormality of the lower motor neuron (HP:0002366) | 4.56085776 |
| 8 | Ependymoma (HP:0002888) | 4.34279850 |
| 9 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.18390660 |
| 10 | Premature rupture of membranes (HP:0001788) | 4.05639527 |
| 11 | Acute necrotizing encephalopathy (HP:0006965) | 4.00088246 |
| 12 | Mitochondrial inheritance (HP:0001427) | 3.96635658 |
| 13 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.91419152 |
| 14 | Abnormal number of erythroid precursors (HP:0012131) | 3.89648240 |
| 15 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.86072974 |
| 16 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.84858249 |
| 17 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.82210243 |
| 18 | Hypoplasia of the fovea (HP:0007750) | 3.82210243 |
| 19 | Neoplasm of striated muscle (HP:0009728) | 3.73917167 |
| 20 | Hepatocellular necrosis (HP:0001404) | 3.70483051 |
| 21 | Rhabdomyosarcoma (HP:0002859) | 3.68782102 |
| 22 | Vertebral compression fractures (HP:0002953) | 3.67534711 |
| 23 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.63662601 |
| 24 | Increased hepatocellular lipid droplets (HP:0006565) | 3.60548769 |
| 25 | Macrocytic anemia (HP:0001972) | 3.60369607 |
| 26 | Embryonal renal neoplasm (HP:0011794) | 3.58765164 |
| 27 | Acute encephalopathy (HP:0006846) | 3.56013388 |
| 28 | Lipid accumulation in hepatocytes (HP:0006561) | 3.50418868 |
| 29 | Increased CSF lactate (HP:0002490) | 3.48409487 |
| 30 | Fused cervical vertebrae (HP:0002949) | 3.43074159 |
| 31 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.35705139 |
| 32 | Abnormal protein glycosylation (HP:0012346) | 3.35705139 |
| 33 | Abnormal glycosylation (HP:0012345) | 3.35705139 |
| 34 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.35705139 |
| 35 | Hepatic necrosis (HP:0002605) | 3.31680774 |
| 36 | Testicular atrophy (HP:0000029) | 3.28476300 |
| 37 | Reduced antithrombin III activity (HP:0001976) | 3.22285015 |
| 38 | Renal Fanconi syndrome (HP:0001994) | 3.17820587 |
| 39 | Bifid tongue (HP:0010297) | 3.17218113 |
| 40 | Rectal fistula (HP:0100590) | 3.15765890 |
| 41 | Rectovaginal fistula (HP:0000143) | 3.15765890 |
| 42 | Trismus (HP:0000211) | 3.12616238 |
| 43 | Chromsome breakage (HP:0040012) | 3.10212417 |
| 44 | Partial duplication of thumb phalanx (HP:0009944) | 3.07915707 |
| 45 | Progressive macrocephaly (HP:0004481) | 3.02092480 |
| 46 | Abnormal cartilage morphology (HP:0002763) | 2.97727977 |
| 47 | Ragged-red muscle fibers (HP:0003200) | 2.96374744 |
| 48 | Vacuolated lymphocytes (HP:0001922) | 2.96095748 |
| 49 | Abnormal lung lobation (HP:0002101) | 2.93114787 |
| 50 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.92890589 |
| 51 | Abnormality of the astrocytes (HP:0100707) | 2.91777554 |
| 52 | Astrocytoma (HP:0009592) | 2.91777554 |
| 53 | Abnormality of the salivary glands (HP:0010286) | 2.90655576 |
| 54 | Abnormality of the fovea (HP:0000493) | 2.88506296 |
| 55 | Short humerus (HP:0005792) | 2.84161921 |
| 56 | Intestinal fistula (HP:0100819) | 2.77436039 |
| 57 | Increased intramyocellular lipid droplets (HP:0012240) | 2.77408093 |
| 58 | Amyotrophic lateral sclerosis (HP:0007354) | 2.76215277 |
| 59 | Aplastic anemia (HP:0001915) | 2.75612691 |
| 60 | Vaginal fistula (HP:0004320) | 2.75235195 |
| 61 | Abnormality of dentin (HP:0010299) | 2.72449382 |
| 62 | Partial duplication of the phalanx of hand (HP:0009999) | 2.69815967 |
| 63 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.66938209 |
| 64 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.66938209 |
| 65 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.63428199 |
| 66 | Cerebral edema (HP:0002181) | 2.61066497 |
| 67 | Anomalous pulmonary venous return (HP:0010772) | 2.58910409 |
| 68 | Rough bone trabeculation (HP:0100670) | 2.58448711 |
| 69 | Type I transferrin isoform profile (HP:0003642) | 2.55828219 |
| 70 | Cervical subluxation (HP:0003308) | 2.54149687 |
| 71 | Increased muscle lipid content (HP:0009058) | 2.52244692 |
| 72 | Preauricular skin tag (HP:0000384) | 2.50980438 |
| 73 | Respiratory difficulties (HP:0002880) | 2.50203215 |
| 74 | Progressive muscle weakness (HP:0003323) | 2.50058529 |
| 75 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.47128431 |
| 76 | Abnormality of the intrinsic pathway (HP:0010989) | 2.46423608 |
| 77 | Respiratory failure (HP:0002878) | 2.45632417 |
| 78 | Protrusio acetabuli (HP:0003179) | 2.42280431 |
| 79 | Shawl scrotum (HP:0000049) | 2.42276638 |
| 80 | Horizontal nystagmus (HP:0000666) | 2.41243204 |
| 81 | Meckel diverticulum (HP:0002245) | 2.40818966 |
| 82 | Hypochromic anemia (HP:0001931) | 2.38206538 |
| 83 | Short 5th finger (HP:0009237) | 2.36312000 |
| 84 | Impulsivity (HP:0100710) | 2.36009015 |
| 85 | Tongue fasciculations (HP:0001308) | 2.34940885 |
| 86 | Increased serum lactate (HP:0002151) | 2.33524476 |
| 87 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.32560098 |
| 88 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.31673104 |
| 89 | Villous atrophy (HP:0011473) | 2.31673104 |
| 90 | Lactic acidosis (HP:0003128) | 2.31072202 |
| 91 | Abnormality of glycolipid metabolism (HP:0010969) | 2.30136210 |
| 92 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.30136210 |
| 93 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.30136210 |
| 94 | Generalized hypotonia (HP:0001290) | 2.27934930 |
| 95 | Glossoptosis (HP:0000162) | 2.27598188 |
| 96 | Exertional dyspnea (HP:0002875) | 2.25783946 |
| 97 | Hand muscle atrophy (HP:0009130) | 2.25166287 |
| 98 | Abnormality of the ileum (HP:0001549) | 2.24704731 |
| 99 | Tetraplegia (HP:0002445) | 2.23604860 |
| 100 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.22937144 |
| 101 | Microretrognathia (HP:0000308) | 2.22226924 |
| 102 | Glioma (HP:0009733) | 2.20412847 |
| 103 | Preauricular pit (HP:0004467) | 2.19100117 |
| 104 | Periauricular skin pits (HP:0100277) | 2.19100117 |
| 105 | Abnormality of the pulmonary veins (HP:0011718) | 2.18354771 |
| 106 | Nasolacrimal duct obstruction (HP:0000579) | 2.16844712 |
| 107 | Abnormality of the musculature of the hand (HP:0001421) | 2.15599039 |
| 108 | Skin tags (HP:0010609) | 2.15509383 |
| 109 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.15285384 |
| 110 | Missing ribs (HP:0000921) | 2.14987448 |
| 111 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.14502131 |
| 112 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 2.13414901 |
| 113 | Microvesicular hepatic steatosis (HP:0001414) | 2.13336511 |
| 114 | Thrombocytosis (HP:0001894) | 2.12298089 |
| 115 | Pallor (HP:0000980) | 2.12239278 |
| 116 | Nonimmune hydrops fetalis (HP:0001790) | 2.10639937 |
| 117 | Prolonged neonatal jaundice (HP:0006579) | 2.10424190 |
| 118 | Abnormality of chromosome segregation (HP:0002916) | 2.10250539 |
| 119 | Muscle fibrillation (HP:0010546) | 2.09757031 |
| 120 | Hyperventilation (HP:0002883) | 2.09362894 |
| 121 | Exercise intolerance (HP:0003546) | 2.08380411 |
| 122 | Large earlobe (HP:0009748) | 2.08330219 |
| 123 | Supernumerary spleens (HP:0009799) | 2.07812695 |
| 124 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.07736923 |
| 125 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.06838112 |
| 126 | Neoplasm of the heart (HP:0100544) | 2.05349291 |
| 127 | Malignant neoplasm of the central nervous system (HP:0100836) | 2.04747426 |
| 128 | Abnormality of the pubic bones (HP:0003172) | 2.04491547 |
| 129 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.04041199 |
| 130 | Degeneration of anterior horn cells (HP:0002398) | 2.00985384 |
| 131 | Abnormality of the anterior horn cell (HP:0006802) | 2.00985384 |
| 132 | Facial cleft (HP:0002006) | 1.99941636 |
| 133 | Increased connective tissue (HP:0009025) | 1.98173545 |
| 134 | Cheilitis (HP:0100825) | 1.97253095 |
| 135 | Spinal muscular atrophy (HP:0007269) | 1.96901273 |
| 136 | Abnormal trabecular bone morphology (HP:0100671) | 1.95872157 |
| 137 | Generalized aminoaciduria (HP:0002909) | 1.94554563 |
| 138 | Duodenal stenosis (HP:0100867) | 1.93647136 |
| 139 | Small intestinal stenosis (HP:0012848) | 1.93647136 |
| 140 | Combined immunodeficiency (HP:0005387) | 1.93197393 |
| 141 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.92105608 |
| 142 | Hypokinesia (HP:0002375) | 1.91976008 |
| 143 | Sensory axonal neuropathy (HP:0003390) | 1.91542456 |
| 144 | Angiofibromas (HP:0010615) | 1.90300886 |
| 145 | Adenoma sebaceum (HP:0009720) | 1.90300886 |
| 146 | 3-Methylglutaconic aciduria (HP:0003535) | 1.90241832 |
| 147 | Renal duplication (HP:0000075) | 1.89631725 |
| 148 | Embryonal neoplasm (HP:0002898) | 1.88189683 |
| 149 | Sparse eyelashes (HP:0000653) | 1.88178027 |
| 150 | Vertebral fusion (HP:0002948) | 1.87692343 |
| 151 | Delayed cranial suture closure (HP:0000270) | 1.87487216 |
| 152 | Esophageal neoplasm (HP:0100751) | 1.86373012 |
| 153 | Neoplasm of head and neck (HP:0012288) | 1.86373012 |
| 154 | Entropion (HP:0000621) | 1.84133795 |
| 155 | Poor head control (HP:0002421) | 1.83872938 |
| 156 | Redundant skin (HP:0001582) | 1.82279740 |
| 157 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.81087650 |
| 158 | Lethargy (HP:0001254) | 1.79964173 |
| 159 | Dysostosis multiplex (HP:0000943) | 1.78608389 |
| 160 | Blue sclerae (HP:0000592) | 1.77151573 |
| 161 | Opisthotonus (HP:0002179) | 1.76819307 |
| 162 | Pancytopenia (HP:0001876) | 1.76485678 |
| 163 | Abnormality of renal resorption (HP:0011038) | 1.73932401 |
| 164 | Glycosuria (HP:0003076) | 1.72157105 |
| 165 | Abnormality of urine glucose concentration (HP:0011016) | 1.72157105 |
| 166 | Hyperphosphaturia (HP:0003109) | 1.71745325 |
| 167 | CNS demyelination (HP:0007305) | 1.71075572 |
| 168 | Beaking of vertebral bodies (HP:0004568) | 1.69632861 |
| 169 | Spastic paraparesis (HP:0002313) | 1.68806183 |
| 170 | Joint stiffness (HP:0001387) | 1.65943344 |
| 171 | Patchy hypopigmentation of hair (HP:0011365) | 1.64869777 |
| 172 | Flat capital femoral epiphysis (HP:0003370) | 1.63976122 |
| 173 | Abnormality of the umbilical cord (HP:0010881) | 1.63498351 |
| 174 | Loss of speech (HP:0002371) | 1.62737599 |
| 175 | Abnormality of placental membranes (HP:0011409) | 1.62679230 |
| 176 | Amniotic constriction ring (HP:0009775) | 1.62679230 |
| 177 | Oral leukoplakia (HP:0002745) | 1.61752095 |
| 178 | Neutropenia (HP:0001875) | 1.61107210 |
| 179 | Optic disc pallor (HP:0000543) | 1.60859715 |
| 180 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.60483334 |
| 181 | Increased serum pyruvate (HP:0003542) | 1.59660551 |
| 182 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.59114105 |
| 183 | Dicarboxylic aciduria (HP:0003215) | 1.58660857 |
| 184 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.58660857 |
| 185 | J-shaped sella turcica (HP:0002680) | 1.55985808 |
| 186 | Abnormality of T cell physiology (HP:0011840) | 1.55687911 |
| 187 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.55678938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 7.98136915 |
| 2 | GRK5 | 5.28112211 |
| 3 | ERN1 | 5.20820517 |
| 4 | VRK2 | 4.69707277 |
| 5 | GRK6 | 4.29265564 |
| 6 | ADRBK2 | 3.28653396 |
| 7 | GRK1 | 3.27084492 |
| 8 | TESK1 | 3.07341254 |
| 9 | STK16 | 2.90639875 |
| 10 | CSF1R | 2.78876198 |
| 11 | TTK | 2.77246096 |
| 12 | TGFBR2 | 2.64043585 |
| 13 | GRK7 | 2.38955747 |
| 14 | MAPK7 | 2.35386519 |
| 15 | LRRK2 | 2.34379732 |
| 16 | TYRO3 | 2.34302595 |
| 17 | LIMK1 | 2.32380375 |
| 18 | STK10 | 2.19563099 |
| 19 | MATK | 2.15369926 |
| 20 | MAP3K12 | 2.13305108 |
| 21 | MOS | 1.96753696 |
| 22 | PBK | 1.89993656 |
| 23 | WNK1 | 1.87582469 |
| 24 | PIM2 | 1.74854513 |
| 25 | CDK7 | 1.74662727 |
| 26 | EPHA2 | 1.74366384 |
| 27 | PRKG2 | 1.68769563 |
| 28 | KDR | 1.62159613 |
| 29 | IRAK3 | 1.47819635 |
| 30 | PAK4 | 1.46121112 |
| 31 | AKT3 | 1.46014364 |
| 32 | NME1 | 1.45703410 |
| 33 | VRK1 | 1.44290419 |
| 34 | NTRK1 | 1.43650088 |
| 35 | EIF2AK1 | 1.41022679 |
| 36 | HIPK2 | 1.40688910 |
| 37 | CAMK4 | 1.36466289 |
| 38 | CHEK2 | 1.30273206 |
| 39 | MYLK | 1.25268107 |
| 40 | PLK1 | 1.21910030 |
| 41 | ILK | 1.20003405 |
| 42 | BRSK1 | 1.18191492 |
| 43 | MARK2 | 1.13331537 |
| 44 | MAP3K10 | 1.11498494 |
| 45 | ADRBK1 | 1.10591776 |
| 46 | ZAK | 1.10441998 |
| 47 | ZAP70 | 1.06899810 |
| 48 | TBK1 | 1.06615496 |
| 49 | ABL2 | 1.04365870 |
| 50 | EPHB2 | 1.00335174 |
| 51 | MST1R | 0.98848844 |
| 52 | PDK2 | 0.97353604 |
| 53 | TLK1 | 0.94920940 |
| 54 | MAP4K1 | 0.94694171 |
| 55 | TYK2 | 0.94316093 |
| 56 | SCYL2 | 0.92803901 |
| 57 | CSNK1G3 | 0.91087807 |
| 58 | ARAF | 0.87924496 |
| 59 | SIK3 | 0.86594463 |
| 60 | SMG1 | 0.84270764 |
| 61 | ERBB4 | 0.82324951 |
| 62 | FGFR3 | 0.81833064 |
| 63 | BUB1 | 0.79593579 |
| 64 | CDC7 | 0.79175413 |
| 65 | CHEK1 | 0.78062130 |
| 66 | DAPK3 | 0.76310259 |
| 67 | LMTK2 | 0.75220576 |
| 68 | EIF2AK2 | 0.75030906 |
| 69 | MAP2K6 | 0.74736823 |
| 70 | WEE1 | 0.73311460 |
| 71 | ALK | 0.71256992 |
| 72 | MAP2K4 | 0.70877937 |
| 73 | AKT2 | 0.70340740 |
| 74 | CSK | 0.67367924 |
| 75 | RPS6KB2 | 0.65441279 |
| 76 | PRKCI | 0.64966135 |
| 77 | DAPK1 | 0.64313457 |
| 78 | CSNK1A1L | 0.63622853 |
| 79 | TXK | 0.63586163 |
| 80 | MAP3K11 | 0.61301709 |
| 81 | NEK2 | 0.60619378 |
| 82 | TRIM28 | 0.59820687 |
| 83 | AURKA | 0.56736148 |
| 84 | PKN2 | 0.56054179 |
| 85 | MAP2K2 | 0.55204075 |
| 86 | CSNK2A2 | 0.55011932 |
| 87 | CSNK2A1 | 0.54685192 |
| 88 | TESK2 | 0.53972435 |
| 89 | MTOR | 0.53144669 |
| 90 | TGFBR1 | 0.51084237 |
| 91 | CSNK1G1 | 0.51052971 |
| 92 | MAP3K7 | 0.48652876 |
| 93 | PTK2 | 0.47903557 |
| 94 | LATS2 | 0.47819700 |
| 95 | CDK2 | 0.47366579 |
| 96 | EPHB1 | 0.47205941 |
| 97 | MAPK12 | 0.46852220 |
| 98 | AURKB | 0.46099008 |
| 99 | BRAF | 0.45805552 |
| 100 | PTK6 | 0.45798859 |
| 101 | IRAK4 | 0.44670772 |
| 102 | IKBKE | 0.44578037 |
| 103 | MAP4K2 | 0.43321825 |
| 104 | TRIB3 | 0.42513707 |
| 105 | JAK3 | 0.40905393 |
| 106 | MAPKAPK3 | 0.40883220 |
| 107 | RPS6KA4 | 0.40866537 |
| 108 | DYRK3 | 0.40646646 |
| 109 | FGFR4 | 0.40444051 |
| 110 | MUSK | 0.40384067 |
| 111 | IGF1R | 0.38534718 |
| 112 | PAK1 | 0.38369666 |
| 113 | CDK4 | 0.38296472 |
| 114 | MAP2K7 | 0.37900922 |
| 115 | NUAK1 | 0.37644269 |
| 116 | FLT3 | 0.36559213 |
| 117 | CDK19 | 0.35751667 |
| 118 | ATM | 0.35413305 |
| 119 | SRPK1 | 0.34752548 |
| 120 | PRKCD | 0.33555578 |
| 121 | PASK | 0.32738634 |
| 122 | DYRK2 | 0.31302974 |
| 123 | NEK1 | 0.30902942 |
| 124 | ITK | 0.30417433 |
| 125 | IKBKB | 0.30341669 |
| 126 | BRSK2 | 0.29140319 |
| 127 | PDGFRA | 0.28737309 |
| 128 | CSNK1E | 0.27417289 |
| 129 | CDK8 | 0.27074852 |
| 130 | DDR2 | 0.25653482 |
| 131 | ERBB2 | 0.25148285 |
| 132 | CDK1 | 0.24641972 |
| 133 | MST4 | 0.22082627 |
| 134 | NME2 | 0.20730506 |
| 135 | MAPK1 | 0.20291351 |
| 136 | TAOK2 | 0.18843190 |
| 137 | MAPK10 | 0.18680439 |
| 138 | INSR | 0.18417268 |
| 139 | EIF2AK3 | 0.17691464 |
| 140 | PRKD2 | 0.17259679 |
| 141 | MAPK14 | 0.17102400 |
| 142 | RIPK1 | 0.15363639 |
| 143 | GSK3B | 0.15170831 |
| 144 | GSK3A | 0.14993602 |
| 145 | DYRK1B | 0.14677318 |
| 146 | MET | 0.13211178 |
| 147 | CHUK | 0.13155642 |
| 148 | PRKACG | 0.12934925 |
| 149 | DYRK1A | 0.12906668 |
| 150 | MAP3K3 | 0.12200169 |
| 151 | BCKDK | 0.12165120 |
| 152 | ATR | 0.11982388 |
| 153 | CDK15 | 0.11638378 |
| 154 | MAPKAPK2 | 0.11600370 |
| 155 | PAK3 | 0.11550825 |
| 156 | CDK11A | 0.11415166 |
| 157 | SIK1 | 0.10510242 |
| 158 | MAPK4 | 0.10456759 |
| 159 | MAP3K8 | 0.10218063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 5.88614309 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.80346167 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 4.24314388 |
| 4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.95284287 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.48671450 |
| 6 | Galactose metabolism_Homo sapiens_hsa00052 | 3.04697013 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.87246782 |
| 8 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.78991471 |
| 9 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.31799779 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.26226448 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.12483637 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.06929210 |
| 13 | RNA transport_Homo sapiens_hsa03013 | 2.05277095 |
| 14 | DNA replication_Homo sapiens_hsa03030 | 2.04816302 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 2.03916477 |
| 16 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.99326287 |
| 17 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.98588282 |
| 18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.97509667 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.90860934 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.85251264 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.79970541 |
| 22 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.76690302 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.76245783 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.73652421 |
| 25 | Mismatch repair_Homo sapiens_hsa03430 | 1.67408590 |
| 26 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.67190437 |
| 27 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.65663791 |
| 28 | Thyroid cancer_Homo sapiens_hsa05216 | 1.60061926 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57831145 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.49417758 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.46919166 |
| 32 | Homologous recombination_Homo sapiens_hsa03440 | 1.41129953 |
| 33 | Cell cycle_Homo sapiens_hsa04110 | 1.37703470 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37001596 |
| 35 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.36351001 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.34341936 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.32264582 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.30343251 |
| 39 | Spliceosome_Homo sapiens_hsa03040 | 1.27174719 |
| 40 | RNA degradation_Homo sapiens_hsa03018 | 1.26607385 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26273687 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.22129358 |
| 43 | RNA polymerase_Homo sapiens_hsa03020 | 1.18936168 |
| 44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.18849943 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 1.14594787 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.13208118 |
| 47 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.12635088 |
| 48 | Base excision repair_Homo sapiens_hsa03410 | 1.12383625 |
| 49 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.04529627 |
| 50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98899540 |
| 51 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.96473695 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.89581570 |
| 53 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.89264941 |
| 54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.87726378 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85337249 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83915805 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83573548 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.82770693 |
| 59 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.80069298 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.79965305 |
| 61 | Purine metabolism_Homo sapiens_hsa00230 | 0.78522664 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78312699 |
| 63 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.75646667 |
| 64 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.74124275 |
| 65 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73807980 |
| 66 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73794412 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73385679 |
| 68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72834248 |
| 69 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70555059 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70274628 |
| 71 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.70048983 |
| 72 | Basal transcription factors_Homo sapiens_hsa03022 | 0.69061711 |
| 73 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67506808 |
| 74 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.66304731 |
| 75 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.66280337 |
| 76 | Protein export_Homo sapiens_hsa03060 | 0.66259390 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.63995940 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63764627 |
| 79 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63245717 |
| 80 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.62463531 |
| 81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.61966048 |
| 82 | Peroxisome_Homo sapiens_hsa04146 | 0.59474015 |
| 83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.58098437 |
| 84 | Shigellosis_Homo sapiens_hsa05131 | 0.57123063 |
| 85 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.56465797 |
| 86 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.56458747 |
| 87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.56294792 |
| 88 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.56212381 |
| 89 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55882044 |
| 90 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.54898035 |
| 91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54639966 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54009648 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53292622 |
| 94 | Bladder cancer_Homo sapiens_hsa05219 | 0.52604777 |
| 95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51890086 |
| 96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51176255 |
| 97 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49647789 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48500943 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48086471 |
| 100 | Proteasome_Homo sapiens_hsa03050 | 0.47401100 |
| 101 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.43715898 |
| 102 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42517095 |
| 103 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.42296380 |
| 104 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.41728255 |
| 105 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.41725275 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40662034 |
| 107 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.39656589 |
| 108 | Phagosome_Homo sapiens_hsa04145 | 0.39428729 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38481756 |
| 110 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37598980 |
| 111 | Allograft rejection_Homo sapiens_hsa05330 | 0.35345470 |
| 112 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.34640896 |
| 113 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.34265719 |
| 114 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33467768 |
| 115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.32648583 |
| 116 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.32100503 |
| 117 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.32077599 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.31891959 |
| 119 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.31404394 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31400486 |
| 121 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30266364 |
| 122 | Apoptosis_Homo sapiens_hsa04210 | 0.30003228 |
| 123 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.29345309 |
| 124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.28565766 |
| 125 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27994139 |
| 126 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.27785888 |
| 127 | Legionellosis_Homo sapiens_hsa05134 | 0.27779912 |
| 128 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.27607522 |
| 129 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.26022329 |
| 130 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25539549 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.24622907 |
| 132 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.24296301 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24187591 |
| 134 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.23725338 |
| 135 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.23383182 |
| 136 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23365506 |
| 137 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.22890633 |
| 138 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.22609269 |
| 139 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.22179199 |
| 140 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.22139793 |
| 141 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.20238665 |
| 142 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.19029532 |
| 143 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.18688832 |
| 144 | HTLV-I infection_Homo sapiens_hsa05166 | 0.18382749 |
| 145 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.18194361 |
| 146 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.17821722 |
| 147 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.17689211 |
| 148 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.17552440 |
| 149 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.13567913 |
| 150 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.12989461 |
| 151 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.12894371 |

